e-Drug3D

1235

CERULETIDE

DISCONTINUED


INN
CERULETIDE

cas 17650-98-5
CLASS

VARIOUS
SPASMOGENIC EFFECT
TESTS FOR BILE DUCT PATENCY
DIAGNOSTIC AGENTS

ROUTE (list)

INJECTION

ATC code

V04CC04

PK parameters

Target

TARGET CHOLECYSTOKININ TYPE A RECEPTOR

DrugCentral

Cholecystokinin receptor type A UNIPROT P32238 CCKAR

Download SDF file (3S)-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2R)-2-[[(2S)-2-[[2-[[(2S,3R)-2-[[(2S)-2-amino-3-(4-sulfooxyphenyl)propanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]hexanoyl]amino]-4-oxobutanoic acid

Formula:
C58H73N13O21S2

Calculated chemical properties:

MW 1350.42
NB_atoms 94
XLogP -7.18
PSA 512.712
NB_HD 17
NB_HA 34
fsp3 0.41
Lipinski(0=no;1=yes) 0

FDA
NDA 018296 (pdf not found) INN (CERULETIDE DIETHYLAMINE) TYMTRAN (PHARMACIA AND UPJOHN) APPROVAL= - YEAR= 0 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL